All year long, these moments captivated the public, demonstrated dangerous trends, and pushed research and innovation forward ...

Detailed price information for Biovaxys Technology Corp (BIOV-CN) from The Globe and Mail including charting and trades.

Sanofi acquires Dynavax for $2.2B, boosting its vaccine portfolio with HEPLISAV-B and a shingles candidate. Click for my ...

Merck declines its option on Evaxion's EVX-B2 gonorrhea vaccine, leaving global rights with Evaxion and no change to its cash ...

Get insights on AbCellera’s high valuation, AI-driven R&D losses, stock-based compensation, and how Canadian funding impacts ...

Moderna Inc. fell in trading Monday after the Food and Drug Administration said in a memo late last week it would place new restrictions on which vaccines hit the market. Vinay Prasad, a top FDA ...

The US Food and Drug Administration intends to put a “black box” warning on Covid-19 vaccines, according to two people familiar with the agency’s plans, the latest move by President Donald Trump’s ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

The agency’s top vaccine regulator proposed broad changes, claiming that a new review linked 10 children’s deaths to the Covid vaccine. But public health experts questioned the findings, wanting to ...

Shares of National Bank of Canada NA rose 1.79% to C$171.12 Tuesday, in what proved to be an otherwise all-around down trading session for the Canadian market, with the S&P/TSX Composite Index GSPTSE ...

Shares of Power Corp. of Canada POW inched 0.32% higher to C$73.12 Friday, in what proved to be an otherwise all-around negative trading session for the Canadian market, with the S&P/TSX Composite ...